These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9550442)

  • 1. Significance of trisomy 7 related to PCNA index in cholesteatoma.
    Lavezzi A; Mantovani M; Cazzulo A; Turconi P; Matturri L
    Am J Otolaryngol; 1998; 19(2):109-12. PubMed ID: 9550442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of trisomy 7 with fluorescence in situ hybridization and its correlation with DNA content and proliferating cell nuclear antigen-positivity in prostate cancer.
    Matturri L; Biondo B; Cazzullo A; Montanari E; Radice F; Timossi R; Turconi P; Lavezzi AM
    Am J Clin Oncol; 1998 Jun; 21(3):253-7. PubMed ID: 9626793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
    Shieh TJ; Ho KY; Kuo WR; Chai CY; Lin CS; Juan KH
    Kaohsiung J Med Sci; 1999 Aug; 15(8):468-74. PubMed ID: 10518363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 8 aneuploidy in acquired cholesteatoma.
    Yildirim MS; Ozturk K; Acar H; Arbag H; Ulku CH
    Acta Otolaryngol; 2003 Apr; 123(3):372-6. PubMed ID: 12737293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and interphase cytogenetic analysis of desmoid tumours.
    Kouho H; Aoki T; Hisaoka M; Hashimoto H
    Histopathology; 1997 Oct; 31(4):336-41. PubMed ID: 9363449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.
    Ecsedi S; Rákosy Z; Vízkeleti L; Juhász A; Sziklai I; Adány R; Balázs M
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):635-40. PubMed ID: 18984256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7.
    Amare Kadam PS; Varghese C; Bharde SH; Narasimhamoorthy NK; Desai S; Advani SH; Havaldar R; Kulkarni JN
    Cancer Genet Cytogenet; 2001 Mar; 125(2):139-46. PubMed ID: 11369057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma.
    Lavezzi AM; Biondo B; Cazzullo A; Giordano F; Pallotti F; Turconi P; Matturri L
    Anticancer Res; 2001; 21(2B):1279-84. PubMed ID: 11396199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
    Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of c-MYC status in primary acquired cholesteatoma by using fluorescence in situ hybridization technique.
    Ozturk K; Yildirim MS; Acar H; Cenik Z; Keles B
    Otol Neurotol; 2006 Aug; 27(5):588-91. PubMed ID: 16868505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative analysis of the proliferative capacity of cholesteatomas].
    Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
    Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of trisomy 8 and monosomy 7 in chronic granulocytic leukemia and myelodysplastic syndrome by cytogenetic analysis and fluorescence in situ hybridization].
    Szabó Gabriella P; Balogh E; Jakab Z; Germán P; Bodnár F; Kiss A; Telek B; Oláh E
    Orv Hetil; 2002 Dec; 143(50):2775-9. PubMed ID: 12583317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on epidermal proliferation ability in cholesteatoma.
    Tanaka Y; Shiwa M; Kojima H; Miyazaki H; Kamide Y; Moriyama H
    Laryngoscope; 1998 Apr; 108(4 Pt 1):537-42. PubMed ID: 9546266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsies.
    Matturri L; Biondo B; Cazzullo A; Colombo B; Giordano F; Guarino M; Pallotti F; Turconi P; Lavezzi AM
    Anticancer Res; 1998; 18(4B):2819-25. PubMed ID: 9713468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
    Durko M; Kaczmarczyk D
    Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of different biomarkers (DNA content, PCNA, karyotype) in colorectal adenomas.
    Lavezzi AM; Ottaviani G; De Ruberto F; Fichera G; Matturri L
    Anticancer Res; 2002; 22(4):2077-81. PubMed ID: 12174886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic aspects of cell proliferation in atherosclerotic plaques.
    Matturri L; Cazzullo A; Turconi P; Lavezzi AM
    Cardiologia; 1997 Aug; 42(8):833-6. PubMed ID: 9286119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferation and apoptosis in human middle ear cholesteatoma.
    Kojima H; Tanaka Y; Tanaka T; Miyazaki H; Shiwa M; Kamide Y; Moriyama H
    Arch Otolaryngol Head Neck Surg; 1998 Mar; 124(3):261-4. PubMed ID: 9525508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of proliferating cell nuclear antigen in aural cholesteatoma.
    Uchida N; Ito S; Hirano M
    Kurume Med J; 1993; 40(4):225-8. PubMed ID: 7911858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of proliferating cell nuclear antigen (PCNA) in the adult and developing mouse nervous system.
    Ino H; Chiba T
    Brain Res Mol Brain Res; 2000 May; 78(1-2):163-74. PubMed ID: 10891596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.